Impact Partnership Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Impact Partnership Wealth's BMY Position: Q2 2026 in Review
Impact Partnership Wealth increased its Bristol-Myers Squibb (BMY) stake by 303% in Q2 2026, buying an estimated $1.55M and bringing the position to 35,952 shares worth $2.07M. The position accounts for 0.2% of the portfolio, ranked #71.
Impact Partnership Wealth first reported a position in BMY in Q2 2023 and has held it in 12 quarters since. 2,526 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Impact Partnership Wealth held 35,952 shares of Bristol-Myers Squibb worth $2.07M as of Q2 2026.
- Impact Partnership Wealth bought 27,032 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.55M.
- Bristol-Myers Squibb made up 0.2% of Impact Partnership Wealth's portfolio in Q2 2026, its #71 holding.
- Impact Partnership Wealth first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 12 quarters since.
- 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Impact Partnership Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.